Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Cornea and External Disease
When should mitomycin intravascular chemoembolization be considered as a treatment for corneal neovascularization?
Related Questions
What supportive care measures do you prioritize to manage or prevent toxicity in patients receiving Dato-DXd?
How would you approach the management of a patient presenting with bilateral central corneal perforations following treatment with Ipilimumab/Nivolumab?
How do you manage corneal ectasia after refractive surgery?
What factors should be considered when deciding whether to perform corneal crosslinking (CXL) in mild cases of keratoconus?
When do you consider performing laser refractive surgery on corneal transplants?
What is the best course of treatment for limbal stem cell deficiency with a perforated corneal ulcer?
How do you predict which patients are most likely to have a positive response to Oxervate?
In patients with corneal edema and a glaucoma drainage tube placed in the AC, under what circumstances would you consider repositioning the tube in the sulcus first versus proceeding directly with endothelial keratoplasty alone?
How should newer pharmacologic agents be integrated into treatment protocols to maximize symptomatic relief while addressing underlying causes such as inflammation and meibomian gland dysfunction in patients with dry eye disease?
How do you approach IOL calculations and selection in patients with keratoconus based on disease severity?
